Industry Presentations
ATTR-CM Oral Treatment Option
Presentations
Identifying Transthyretin Amyloid Cardiomyopathy & Exploring an Oral Treatment Option
Speakers: Barry Trachtenberg, MD, FACC Duration: 20 minutes
Presented on: July 9, 2020
*This session is not eligible for AMA PRA Category 1 CreditsTM
Speakers